5,020 Shares in CVS Health Co. (NYSE:CVS) Bought by Pines Wealth Management LLC

Pines Wealth Management LLC purchased a new stake in CVS Health Co. (NYSE:CVS - Free Report) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 5,020 shares of the pharmacy operator's stock, valued at approximately $340,000.

A number of other institutional investors have also recently made changes to their positions in CVS. SeaCrest Wealth Management LLC boosted its holdings in CVS Health by 4.4% in the first quarter. SeaCrest Wealth Management LLC now owns 8,136 shares of the pharmacy operator's stock valued at $551,000 after acquiring an additional 344 shares during the last quarter. Procyon Advisors LLC bought a new stake in shares of CVS Health in the 1st quarter valued at $2,065,000. AGH Wealth Advisors LLC bought a new stake in shares of CVS Health in the 1st quarter valued at $230,000. Next Level Private LLC bought a new stake in shares of CVS Health in the 1st quarter valued at $266,000. Finally, Stablepoint Partners LLC boosted its stake in shares of CVS Health by 28.1% in the 1st quarter. Stablepoint Partners LLC now owns 98,316 shares of the pharmacy operator's stock valued at $6,661,000 after purchasing an additional 21,575 shares during the last quarter. Institutional investors own 80.66% of the company's stock.

CVS Health Trading Up 0.8%

Shares of CVS stock opened at $63.61 on Friday. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.81 and a quick ratio of 0.60. CVS Health Co. has a 1 year low of $43.56 and a 1 year high of $72.51. The stock has a market capitalization of $80.47 billion, a price-to-earnings ratio of 17.38, a PEG ratio of 0.98 and a beta of 0.56. The company's fifty day simple moving average is $65.21 and its two-hundred day simple moving average is $59.92.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, topping the consensus estimate of $1.62 by $0.63. The firm had revenue of $94.59 billion for the quarter, compared to analysts' expectations of $93.07 billion. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. The business's quarterly revenue was up 7.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.31 earnings per share. As a group, analysts anticipate that CVS Health Co. will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, May 1st. Investors of record on Tuesday, April 22nd were paid a $0.665 dividend. The ex-dividend date of this dividend was Tuesday, April 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 4.18%. CVS Health's dividend payout ratio is presently 63.48%.

Analyst Upgrades and Downgrades

A number of analysts have commented on the stock. Wolfe Research upped their price target on shares of CVS Health from 67.00 to 70.00 and gave the company an "overweight" rating in a research report on Tuesday, February 11th. Leerink Partnrs upgraded CVS Health from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, February 12th. Robert W. Baird increased their price target on CVS Health from $51.00 to $71.00 and gave the stock a "neutral" rating in a report on Tuesday, April 15th. Morgan Stanley reissued an "overweight" rating on shares of CVS Health in a research note on Tuesday, April 15th. Finally, Royal Bank of Canada increased their target price on shares of CVS Health from $74.00 to $81.00 and gave the stock an "outperform" rating in a research note on Monday, May 5th. Two research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $74.75.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.